Alexander Spira, MD, PhD, FACP

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Boehringer Ingelheim
    Date added:
    08/16/2023
    Date updated:
    08/16/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Astellas Pharma
    Date added:
    08/16/2023
    Date updated:
    08/16/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    MedImmune
    Date added:
    08/16/2023
    Date updated:
    08/16/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Novartis
    Date added:
    08/16/2023
    Date updated:
    08/16/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Incyte
    Date added:
    08/16/2023
    Date updated:
    08/16/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Abbvie
    Date added:
    08/16/2023
    Date updated:
    08/16/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Ignyta
    Date added:
    08/16/2023
    Date updated:
    08/16/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Macrogenics
    Date added:
    08/16/2023
    Date updated:
    08/16/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    CytomX Therapeutics
    Date added:
    08/16/2023
    Date updated:
    08/16/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Astex Pharmaceuticals
    Date added:
    08/16/2023
    Date updated:
    08/16/2023

Pages

Return to 2023 Annual Symposium For Evolving Therapies and Drug Development in Oncology: Targeted therapy, immunotherapy and beyond